Fap clinical trials

Explore recruiting fap clinical trials.

Recruiting fap studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fap trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

LuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu FAP 2286 in Participants with an Advanced Solid Tumor

Italy, Spain, Belgium, France

Therapeutic exploratory (Phase II) EU CTIS Study details

LIBERATE; From Inflammation Biomarkers to Remodelling (FAPI PET/CT) towards personalized diagnosis in post-acute sequelae of COVID-19

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Participants with Familial Adenomatous Polyposis

Denmark, Spain, Germany, Netherlands, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

[18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study (PLASTIC-3-study)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Fap trials by city

Fap in Toronto Fap in Vancouver Fap in Montreal Fap in Calgary Fap in Edmonton Fap in Ottawa Fap in Winnipeg Fap in Quebec City Fap in Hamilton Fap in Kitchener Fap in London Fap in Halifax Fap in New York Fap in Los Angeles Fap in Chicago Fap in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease